Brief: China NT Pharma Group Company Sees A Loss For Six Months
31/07/2020 16:24
July 31 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* EXPECTED TO RECORD A LOSS FOR SIX MONTHS
* EXPECTED RESULT AS GROUP'S SALES REVENUE WAS HINDERED BY
DECLINE
IN NUMBER OF OUTPATIENT VISITS & HOSPITALIZED PATIENTS
Source text for Eikon: ID:nHKS79VHXZ
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY